![Bärbel Brumme-Bothe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bärbel Brumme-Bothe
Chairman at Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Profile
Bärbel Brumme-Bothe is currently the Chairman of the Supervisory Board at Max-Delbrück-Centrum für Molekulare Medizin (MDC) and Principal at Germany Ministry of Education & Research.
Previously, he was the Chairman at German Cancer Research Center and Chairman of the Supervisory Board at Helmholtz-Zentrum für Infektionsforschung GmbH.
Bärbel Brumme-Bothe active positions
Companies | Position | Start |
---|---|---|
Germany Ministry of Education & Research | Corporate Officer/Principal | - |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
![]() Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Chairman | - |
Former positions of Bärbel Brumme-Bothe
Companies | Position | End |
---|---|---|
German Cancer Research Center
![]() German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Chairman | - |
Helmholtz-Zentrum für Infektionsforschung GmbH
![]() Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
German Cancer Research Center
![]() German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
![]() Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
Helmholtz-Zentrum für Infektionsforschung GmbH
![]() Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Health Technology |
Germany Ministry of Education & Research | Government |
- Stock Market
- Insiders
- Bärbel Brumme-Bothe